Cargando…
ENGINEERING T CELLS TARGETING GPC2 FOR TREATING NEUROBLASTOMA
BACKGROUND AND SIGNIFICANCE: Neuroblastoma is a rare pediatric cancer that forms in immature nerve tissue of infants and accounts for 10 to 15 percent of cancer-related deaths in children. The five-year survival for high-risk neuroblastoma is 50% with current treatment practices being a combination...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370431/ http://dx.doi.org/10.1093/abt/tbad014.023 |